Log In
Print
BCIQ
Print
Print this Print this
 

DCP-001

  Manage Alerts
Collapse Summary General Information
Company DCPrime B.V.
DescriptionOff-the-shelf dendritic cell vaccine based on DCOne technology
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today